Related Experiment Video
Updated: Feb 12, 2026

The Preparation of Electrohydrodynamic Bridges from Polar Dielectric Liquids
Published on: September 30, 2014
Structural Evidence for Rifampicin Monooxygenase Inactivating Rifampicin by Cleaving Its Ansa-Bridge
Li-Kai Liu, Yumin Dai1, Heba Abdelwahab1
1Department of Biochemistry , Virginia Tech , Blacksburg , Virginia 24061 , United States.
Abstract:
Rifampicin monooxygenase (RIFMO) decreases the potency of rifampicin (RIF) by converting it to oxidative products. Further decomposition of RIF has been observed in bacteria producing RIFMO and contributes to RIFMO-mediated drug resistance. Here we report the first crystal structure of RIFMO in complex with the hydroxylated RIF product. The 2.10 Å resolution structure reveals a breach of the ansa aliphatic chain of RIF between naphthoquinone C2 and amide N1. Our data suggest that RIFMO catalyzes the hydroxylation of RIF at the C2 atom followed by cleavage of the ansa linkage, which leads to inactivation of the antibiotic by preventing key contacts with the RNA polymerase target.
Insights
Rifampicin monooxygenase (RIFMO) inactivates rifampicin (RIF) by hydroxylation and ansa cleavage. This structural study reveals how RIFMO-mediated drug resistance occurs, impacting antibiotic efficacy.
Area of Science:
- Biochemistry
- Structural Biology
- Microbiology
Background:
- Rifampicin (RIF) is a crucial antibiotic, but resistance mechanisms limit its effectiveness.
- Rifampicin monooxygenase (RIFMO) confers resistance by metabolizing RIF into inactive products.
- Understanding RIFMO's mechanism is vital for combating antibiotic resistance.
Purpose of the Study:
- To determine the first crystal structure of RIFMO in complex with its hydroxylated RIF product.
- To elucidate the molecular mechanism by which RIFMO inactivates RIF.
- To provide insights into RIFMO-mediated antibiotic resistance.
Main Methods:
- X-ray crystallography was used to obtain the RIFMO-RIF product complex structure at 2.10 Å resolution.
- Biochemical assays were employed to study RIFMO activity and product formation.
- Structural analysis focused on the interaction between RIFMO and the modified RIF molecule.
Main Results:
- The crystal structure revealed the hydroxylation of RIF at the C2 atom and subsequent cleavage of the ansa aliphatic chain.
- The ansa chain breach occurs between the naphthoquinone C2 and amide N1.
- This structural insight explains the inactivation of RIF by preventing target binding.
Conclusions:
- RIFMO inactivates RIF through a two-step process: hydroxylation followed by ansa chain cleavage.
- The elucidated mechanism explains RIFMO-mediated drug resistance at a molecular level.
- This study provides a structural basis for understanding and potentially overcoming RIF resistance.
Related Concept Videos
X-Inactivation
The Evidence for Evolution
Design Example: Strain Gauge Bridge or Wheatstone Bridge
Wheatstone Bridge
Thus, for accurate resistance measurements, a...
Bridge rectifier
Operationally, the bridge rectifier allows current flow through two of its diodes during each...
Cross-bridge Cycle

